GlassScriptPhysician profile
Alyssa Ashley
NPI 1851913792
$3,598.34
in general payments reported to CMS, 2019-2025
13 companies · $766 in 2025
The $766 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.17 · 2021: $183 · 2022: $717 · 2023: $1,458 · 2024: $430 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,936 · Travel and Lodging: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,935.58 |
| Travel and Lodging | $719.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,873.12 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $671.78 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $380.42 | 2020-2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $171.14 | 2024-2025 | Xdemvy |
| Lkc Technologies, INC. | $120.14 | 2025 | |
| Optos, INC. | $93.96 | 2022 | |
| Alcon Vision LLC | $82.52 | 2021-2024 | Precision 1 |
| Abbvie INC. | $69.98 | 2022-2023 | Vuity |
| Abb Con-Cise Optical Group LLC | $61.08 | 2022-2023 | Spectacle Lenses, Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.42 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $18.36 | 2020 | |
| Biotissue Holdings INC. | $16.00 | 2025 | |
| Kala Pharmaceuticals, INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Ashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.